T. Rowe Price Associates’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $466K | Sell |
|
|||||
|
2025
Q1 | $397K | Buy |
|
|||||
|
2024
Q4 | $372K | Buy |
|
|||||
|
2024
Q3 | $363K | Buy |
|
|||||
|
2024
Q2 | $268K | Buy |
|
|||||
|
2024
Q1 | $200K | Buy |
|
|||||
|
2023
Q4 | $166K | Buy |
|
|||||
|
2023
Q3 | $180K | Buy |
|
|||||
|
2023
Q2 | $185K | Hold |
|
|||||
|
2023
Q1 | $207K | Buy |
|
|||||
|
2022
Q4 | $174K | Buy |
|
|||||
|
2022
Q3 | $171K | Buy |
|
|||||
|
2022
Q2 | $222K | Buy |
|
|||||
|
2022
Q1 | $227K | Buy |
|
|||||
|
2021
Q4 | $225K | Sell |
|
|||||
|
2021
Q3 | $244K | Hold |
|
|||||
|
2021
Q2 | $327K | Buy |
|
|||||
|
2021
Q1 | $269K | Sell |
|
|||||
|
2020
Q4 | $6.51M | Sell |
|
|||||
|
2020
Q3 | $10.2M | Buy |
|
|||||
|
2020
Q2 | $15.3M | Sell |
|
|||||
|
2020
Q1 | $14.2M | Sell |
|
|||||
|
2019
Q4 | $14.7M | Sell |
|
|||||
|
2019
Q3 | $13.1M | Buy |
|
|||||
|
2019
Q2 | $19.5M | Sell |
|
|||||
|
2019
Q1 | $20.2M | Sell |
|
|||||
|
2018
Q4 | $19.8M | Buy |
|
|||||
|
2018
Q3 | $26.1M | Buy |
|
|||||
|
2018
Q2 | $26.3M | Buy |
|
|||||
|
2018
Q1 | $19.8M | Buy |
|
|||||
|
2017
Q4 | $15.5M | Buy |
|
|||||
|
2017
Q3 | $16.5M | Buy |
|
|||||
|
2017
Q2 | $15.1M | Buy |
|
|||||
|
2017
Q1 | $10.6M | Buy |
|
|||||
|
2016
Q4 | $10.5M | Sell |
|
|||||
|
2016
Q3 | $10.6M | Sell |
|
|||||
|
2016
Q2 | $7.32M | Sell |
|
|||||
|
2016
Q1 | $10.9M | Buy |
|
|||||
|
2015
Q4 | $12.1M | Buy |
|
|||||
|
2015
Q3 | $10.4M | Buy |
|
|||||
|
2015
Q2 | $9.86M | Buy |
|
|||||
|
2015
Q1 | $7.36M | Buy |
|
|||||
|
2014
Q4 | $3.4M | Buy |
|